Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

        FDA User Fee Programs

Medical Device User Fee Amendments (MDUFA)

                        
                MDUFA Cover Sheets
          MDUFA Guidance Documents
          MDUFA Reports Home
          For Industry
          FDA User Fee Programs
          Medical Device User Fee Amendments (MDUFA)FDA User Fee Programs Medical Device User Fee Amendments (MDUFA)
  	
        Share
    Post
    Linkedin

    Email
    PrintUser Fees for FY 2024

Annual Establishment Registration Fee: $7,653

All establishments must pay the establishment registration fee. There are no waivers or reductions for small establishments, businesses, or groups in FY 2024.

Other fees for Fiscal Year 2024 (October 1, 2023, through September 30, 2024) are:

**Application Type**
			**Standard Fee**
			**Small Business Fee***†*510(k)*‡*
			$21,760
			$5,440513(g)
			$6,528
			$3,264PMA, PDP, PMR, BLA
			$483,560
			$120,890De Novo Classification Request
			$145,068
			$36,267Panel-track Supplement
			$386,848
			$96,712180-Day Supplement
			$72,534
			$18,134Real-Time Supplement
			$33,849
			$8,462BLA Efficacy Supplement
			$483,560
			$120,89030-Day Notice
			$7,737
			$3,869Annual Fee for Periodic Reporting on a Class III device (PMAs,PDPs, and PMRs)
			$16,925
			$4,231

*† **Small Business Fee:** For businesses certified by the Center for Devices and Radiological Health (CDRH) as a small business.*

*‡ **510(k) Fees:** All types of 510(k)s (Traditional, Abbreviated, and Special) are subject to the user fee. However, there is no user fee for 510(k)s submitted to the FDA on behalf of an FDA-accredited third-party reviewer.*

Reauthorization Activities
	Medical Device User Fee Amendments 2022 (MDUFA V)
	Medical Device User Fee Amendments 2017 (MDUFA IV)
	Medical Device User Fee Amendments 2012 (MDUFA III)
	Medical Device User Fee Amendments 2007 (MDUFA II)
	Medical Device User Fee and Modernization Act 2002 (MDUFMA)

Background and Legislation
	Device user fees were first established in 2002 by the Medical Device User Fee and Modernization Act (MDUFMA). User fees were renewed in:

2007, with the Medical Device User Fee Amendments (MDUFA II) to the FDA Amendments Act (FDAAA)
	2012, with the Medical Device User Fee Amendments (MDUFA III) to the FDA Safety and Innovation Act (FDASIA)
	2017, with the Medical Device User Fee Amendments (MDUFA IV) to the FDA Reauthorization Act (FDARA). MDUFA IV will be in place from Oct. 1, 2017 until Sept. 30, 2022.
	2022, with the Medical Device User Fee Amendments (MDUFA V) to the Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023. MDUFA V will be in place from Oct. 1, 2022 until Sept. 30, 2027.Under the user fee system, medical device companies pay fees to the FDA when they register their establishments and list their devices with the agency, whenever they submit an application or a notification to market a new medical device in the U.S. and for certain other types of submissions. These fees help the FDA increase the efficiency of regulatory processes with a goal of reducing the time it takes to bring safe and effective medical devices to the U.S. market.

Small Businesses
	**Waivers:** Small businesses with an approved Small Business Determination (SBD) with gross receipts or sales of $30 million or less are eligible to have the fee waived on their first Premarket Approval Application (PMA), Product Development Protocol (PDP), Premarket Report (PMR), or Biologics License Application (BLA).

**Reduced Fees:** Small businesses with an approved Small Business Determination (SBD) with gross receipts or sales of $100 million or less are eligible for a reduced fee on: Premarket Notification (510(k)), De Novo request, Premarket Applications (Premarket Approval Application (PMA), Biologics License Application (BLA), Product Development Protocol (PDP), Premarket Report (PMR), PMA/BLA Supplements and PMA Annual Reports, and 513(g) request for classification information.

**Submitting a Small Business Certification Request:**CDRH's Small Business Program determines whether a business is qualified and certified as a "small business" and eligible for a reduced fee for some types of CDRH submissions that require a user fee. For details on submitting a certification request, see Reduced Medical Device User Fees: Small Business Determination (SBD) Program.

Guidances
	FDA and Industry Actions on Premarket Notification (510(k)) Submissions: Effect on FDA Review Clock and Goals
	FDA and Industry Actions on De Novo Classification Requests: Effect on FDA Review Clock and Goals
	FDA and Industry Actions on Premarket Approval Applications (PMAs): Effect on FDA Review Clock and Goals
	User Fees and Refunds for De Novo Classification Requests
	User Fees and Refunds for Premarket Approval Applications and Device Biologics License Applications
	User Fees and Refunds for Premarket Notification Submissions (510(k)s)
	User Fees and Refunds for 513(g) Requests for Information
	Medical Device User Fee Small Business Qualification and Certification: Guidance for Industry, Food and Drug Administration Staff and Foreign GovernmentsFor other guidance documents, see MDUFA Guidance Documents.

Contact Us
	OPEQSubmissionSupport@fda.hhs.gov

                                                                                  Content current as of:
      09/29/2023
                  
                   
Regulated Product(s)
		 Medical DevicesMedical Device User Fee Amendments (MDUFA)                
                          

                        MDUFA Cover Sheets
          MDUFA Guidance Documents
          MDUFA Reports
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop